Disruption of Escherichia coli Nissle 1917 K5 capsule biosynthesis, through loss of distinct kfi genes, modulates interaction with intestinal epithelial cells and impact on cell health

PloS One
Jonathan NzakizwanayoBrian V Jones

Abstract

Escherichia coli Nissle 1917 (EcN) is among the best characterised probiotics, with a proven clinical impact in a range of conditions. Despite this, the mechanisms underlying these "probiotic effects" are not clearly defined. Here we applied random transposon mutagenesis to identify genes relevant to the interaction of EcN with intestinal epithelial cells. This demonstrated mutants disrupted in the kfiB gene, of the K5 capsule biosynthesis cluster, to be significantly enhanced in attachment to Caco-2 cells. However, this phenotype was distinct from that previously reported for EcN K5 deficient mutants (kfiC null mutants), prompting us to explore further the role of kfiB in EcN:Caco-2 interaction. Isogenic mutants with deletions in kfiB (EcNΔkfiB), or the more extensively characterised K5 capsule biosynthesis gene kfiC (EcNΔkfiC), were both shown to be capsule deficient, but displayed divergent phenotypes with regard to impact on Caco-2 cells. Compared with EcNΔkfiC and the EcN wild-type, EcNΔkfiB exhibited significantly greater attachment to Caco-2 cells, as well as apoptotic and cytotoxic effects. In contrast, EcNΔkfiC was comparable to the wild-type in these assays, but was shown to induce significantly greater COX-2 expressi...Continue Reading

References

Apr 14, 1999·Molecular Microbiology·C Whitfield, I S Roberts
Oct 24, 2000·International Journal of Medical Microbiology : IJMM·P Klemm, M A Schembri
Dec 6, 2000·Microbiology and Molecular Biology Reviews : MMBR·G S Chilcott, K T Hughes
Jan 5, 2002·Gastroenterology Clinics of North America·J L Wallace
Feb 14, 2002·Trends in Molecular Medicine·Jonathan M Rhodes, Barry J Campbell
Aug 7, 2003·Applied and Environmental Microbiology·Andrea HannaAnneta Razatos
Feb 20, 2004·Journal of Bacteriology·Mark A SchembriPer Klemm
Aug 5, 2004·Journal of Bacteriology·Lubomir GrozdanovUlrich Dobrindt
Sep 24, 2004·Immunology·Eva M Pålsson-McDermott, Luke A J O'Neill
Jan 12, 2005·Current Pharmaceutical Design·G C O'SullivanF Shanahan
Apr 7, 2006·Applied and Environmental Microbiology·Alexandra E Bloor, Rocky M Cranenburgh
Jun 8, 2006·Annual Review of Biochemistry·Chris Whitfield
Feb 9, 2007·European Journal of Pediatrics·Jobst HenkerJürgen Schulze
Feb 2, 2008·Inflammatory Bowel Diseases·Michael Schultz
Nov 26, 2008·Advances in Applied Microbiology·David Corbett, Ian S Roberts
Jan 1, 2009·Nutrition and Cancer·Jan-Michel OtteFrank Schmitz
Jun 10, 2009·The Journal of Physiology·Fergus Shanahan

❮ Previous
Next ❯

Methods Mentioned

BETA
IECs
restriction digest
PCR
PCRs
Assay
electrophoresis
gene knockout

Software Mentioned

Olympus Cell Sense
Prism
Graphpad
BlastX

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Caspases in Metabolic Diseases

Caspases, the family of cysteine proteases are involved in programmed cell death, but their role in metabolic diseases, inflammation and immunity has been of interested. Discover the latest research on caspases in metabolic diseases here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis